REBOA: The Dark Side COL Matthew J. Martin, MD Madigan Army Medical - - PowerPoint PPT Presentation

reboa the dark side
SMART_READER_LITE
LIVE PREVIEW

REBOA: The Dark Side COL Matthew J. Martin, MD Madigan Army Medical - - PowerPoint PPT Presentation

2016 Austin Trauma Critical Care Conference REBOA: The Dark Side COL Matthew J. Martin, MD Madigan Army Medical Center Taking the Winning Position R esuscitative E ndovascular B alloon O cclusion of the A orta REBOA is a GREAT idea


slide-1
SLIDE 1

REBOA: The Dark Side

COL Matthew J. Martin, MD Madigan Army Medical Center Taking the Winning Position

2016 Austin Trauma Critical Care Conference

slide-2
SLIDE 2

R E B O A

esuscitative ndovascular alloon

  • rta

cclusion of the

slide-3
SLIDE 3

REBOA is a GREAT idea

slide-4
SLIDE 4

REBOA is a GREAT idea

 Known pathology  No OTHER problems  Have some time  Vascular surgeon  Controlled access

and placement

slide-5
SLIDE 5

The “Unstable” Trauma Patient

 Chaotic  Unclear extent of injuries  Unclear location of injuries

 could be harmful w REBOA

 Trauma/EM doc with less experience  Access much more difficult  Scoop and RUN! May have only one shot

slide-6
SLIDE 6
slide-7
SLIDE 7

Early Complications

slide-8
SLIDE 8
slide-9
SLIDE 9
slide-10
SLIDE 10
slide-11
SLIDE 11

More Vascular Complications?

slide-12
SLIDE 12

Animal Studies

 Anesthetized healthy animal  Controlled OR environment  Single injury – usually vascular  Direct vascular access  Perfect placement  NON survival

slide-13
SLIDE 13

Norii T, et al. J Trauma and Acute Care Surg, 2015

slide-14
SLIDE 14
slide-15
SLIDE 15
slide-16
SLIDE 16

 41 Studies  "Evidence base is weak"  "NO clear reduction in mortality"  Significant device-related morbidity

reported

slide-17
SLIDE 17
slide-18
SLIDE 18

“REBOA would appear to be well suited to the geography of Scotland, which includes a spectrum of topography ranging from major urban lowland regions to rural Northern and island territories. Morrison JJ. The Surgeon. 2014

slide-19
SLIDE 19

Direct to OR

slide-20
SLIDE 20
slide-21
SLIDE 21

Massive Ischemia-Reperfusion Injury

slide-22
SLIDE 22

Massive Ischemia-Reperfusion Injury

30 minutes 30 minutes 60 minutes 60 minutes

slide-23
SLIDE 23

The Clock is Ticking!

slide-24
SLIDE 24

Adjunct for Nonoperative Management?

slide-25
SLIDE 25

Key Points

REBOA is unproven and experimental Potential benefit in VERY FEW scenarios Major risks of complications from placement Major risks of complications from aortic occlusion NOT ready for widespread adoption